Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 62 clinical trials
One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer (HYPORTAdjuvant)

) (Time from randomization to death) Invasive Disease-free survival (iDFS) (Time from randomization to any invasive disease recurrence, death due to any cause or second invasive malignancy)

breast cancer
adjuvant radiotherapy
cancer
mastectomy
sentinel lymph node biopsy
  • 29 views
  • 25 Feb, 2022
  • 1 location
Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV)

ctDNA detection in patients with previously treated, HPV-induced, stage II or III invasive pelvic cancer and who are currently in post-treatment follow-up.

  • 0 views
  • 08 Jul, 2022
  • 5 locations
Liquid Biopsies for the Personalized Management of Patients With Hereditary Diffuse Gastric Cancer

Activating somatic mutations and methylation profiles identified by liquid biopsies could identify CDH1 and CTNNA1 pathogenic variants carriers with invasive diffuse gastric cancer undetectable by upper G-I endoscopy.

  • 0 views
  • 27 Jan, 2021
  • 1 location
Movement and Health Beyond Care (MoviS) (MoviS)

MoviS is a randomized controlled trial on the effect of aerobic exercise training on quality of life (QoL) among breast cancer (BC) survivors. Patients randomized to the intervention arm will receive lifestyle recommendations (nutrition and exercise) and will undergo the MoviS Training program, whereas control arm patients will receive lifestyle …

  • 0 views
  • 08 Jun, 2022
  • 2 locations
Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)

The purpose of this study is to compare the predictive value in terms of specificity of circulating tumor DNA (ctDNA) and positron emission computed tomography (PET-CT) after 2 cycles of chemotherapy (C2), on the probability of obtaining a metabolic complete response after 4 cycles of induction chemotherapy (C4) in patients …

  • 0 views
  • 09 Apr, 2021
  • 2 locations
SBRT in Early Breast Cancer in Elderly Women

Surgical treatment represents the standard of local therapy in patients with early breast cancer, however in women over75, the comorbidities related to aging reduce the possibility of candidates for surgical treatment. In the United Kingdom it is estimated that over 40% of elderly women do not receive surgery for their …

  • 0 views
  • 16 Oct, 2021
  • 1 location
Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast (ROMANCE)

, WBRT did not impact on overall survival, survival of patients who recurred with invasive cancers was impaired in comparison to patients who did not recur, or to patients with DCIS-only recurrences.

lobular carcinoma
ductal carcinoma
progesterone receptor
carcinoma
mammogram
  • 52 views
  • 04 Oct, 2022
  • 28 locations
INSPIRE-AYA: A Multicenter Interactive Survivorship Program to Improve Healthcare Resources for Adolescent and Young Adult (AYA) Cancer Survivors

This trial studies how well an interactive survivorship program works in improving healthcare resources in adolescent and young adult cancer survivors. By improving access to survivorship resources, health literacy, self-management skills, and support, an interactive survivorship program may help to improve adherence to adolescent and young adult healthcare guidelines and …

leukemia
chemotherapy regimen
cancer
lymphoma
cancer chemotherapy
  • 0 views
  • 24 Oct, 2022
  • 1 location
Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue

This study compares molecular breast imaging (MBI) and digital breast tomosynthesis (DBT) in screening patients with dense breast tissue. Breast imaging may help doctors find breast cancer sooner, when it may be easier to treat. Molecular breast imaging (MBI) uses an injection of a small amount of radioactive material that …

breast cancer
mammogram
breast imaging reporting and data system
Accepts healthy volunteers
cancer
  • 17 views
  • 17 Jun, 2022
  • 2 locations
Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania (TOCEM)

This is a prospective clinical trial that will examine if contrast-enhanced mammography substantially improves breast cancer detection compared to mammography with tomosynthesis, with minimal increase in false-positives, in women with a personal history of breast cancer.

breast cancer
primary cancer
mammogram
Accepts healthy volunteers
tomosynthesis
  • 0 views
  • 07 Oct, 2022
  • 3 locations